En Banc Second Circuit Reinstates Conviction Despite Government Retention of ESI
Funds Talk: June 2016
Please use the form below to search for any relevant publications pertaining to your specific needs. If you would like to be added to Kramer Levin's publications distribution list, please click onto the Publications Sign Up in the right side bar.
The firm's work on many significant bankruptcies of the past year has again earned the firm a nod as a finalist for Law Firm of the Year in M&A Advisor’s 2011 Turnaround Awards.
Kramer Levin is regarded as one of the premiere firms engaged in representing unsecured creditors' committees. The firm also represents agent banks in both in-court and out-of-court debt restructuring of middle-market companies, bank groups, equity committees, debtor-in-possession lenders and acquirers in the purchase and sale of securities and assets of troubled companies. On the debtor side, the firm currently represents Saint Vincent Catholic Medical Centers as chapter 11 debtors in a high-profile, complex healthcare restructuring, and Molecular Insight Pharmaceuticals, Inc., as chapter 11 debtors in the restructuring of the clinical stage biopharmaceutical company. Kramer Levin has also been actively involved in the emerging area of municipal and quasi-municipal bankruptcies and chapter 9 proceedings, representing, bondholder groups or indenture trustees in the Las Vegas Monorail case and the Connector 2000 Association chapter 9 proceeding.
M&A Advisor will announce the winner at its annual Turnaround Awards dinner on March 7.
In addition to Law Firm of the Year, M&A Advisor named Kramer Levin a finalist for Turnaround of the Year (Upper Middle Market) and Chapter 11 Reorganization of the Year (Upper Middle Market) for the firm’s work on Cooper-Standard Holdings, Inc.